← All organizations
Highest phase reached
Phase 4
Timeline
2010s
- Feb 1, 2019
prabotulinumtoxinA— Marketing Organization
- Feb 1, 2019
prabotulinumtoxinA— NDA Organization
Drugs by trial phase (5 distinct, 9 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Marketed drugs (1)
Recent trials (14)
- NCT06903975CollaboratorPhase 4May 14, 2025
- NCT06604832CollaboratorPhase 1Sep 3, 2024
- NCT05807412CollaboratorEarly Phase 1May 1, 2023
- NCT05320393Lead sponsorPhase 2Mar 30, 2022
- NCT05320393Study directorPhase 2Mar 30, 2022
- NCT05129319CollaboratorEarly Phase 1Nov 30, 2021
- NCT02428608Lead sponsorPhase 2May 1, 2015
- NCT02428608Study directorPhase 2May 1, 2015
- NCT02334436Study directorPhase 3Jan 1, 2015
- NCT02334436Lead sponsorPhase 3Jan 1, 2015
- NCT02334423Study directorPhase 3Jan 1, 2015
- NCT02334423Lead sponsorPhase 3Jan 1, 2015
- NCT02184988Lead sponsorPhase 2Aug 1, 2014
- NCT02184988Study directorPhase 2Aug 1, 2014
Details
- Founded
- Irvine, CA, US
- Last known activity
- May 14, 2025